Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Manufacturing Failures Place GMP Compliance in Spotlight

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
Aug 2, 2010

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.

Transparency to Alter FDA and Industry Practices

More information may be released to improve public understanding of regulatory policies.
Jul 2, 2010

More information may be released to improve public understanding of regulatory policies.

Securing the Supply Chain

FDA and industry seek to ensure drug quality and safety in a world complicated by global outsourcing and rising theft.
Jun 2, 2010

FDA and industry seek to ensure drug quality and safety in a world complicated by global outsourcing and rising theft.

Health Reform to Transform Coverage, Costs

Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.
May 2, 2010

Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.

Risks and Realities of REMS

FDA lacks resources to manage expanding postmarketing responsibilities.
Apr 2, 2010

FDA lacks resources to manage expanding postmarketing responsibilities.

Pharma Cheers Health Reform Legislation

After months of increasingly rancorous debate, the House finally approved legislation on Mar. 21, 2010, that makes significant changes in the nation's healthcare system.
Mar 22, 2010

After months of increasingly rancorous debate, the House finally approved legislation on Mar. 21, 2010, that makes significant changes in the nation's healthcare system.

Health IT Promises More Timely Drug Information

FDA modernizes information systems, expands access to drug safety and use information.
Mar 2, 2010

FDA modernizes information systems, expands access to drug safety and use information.

Manufacturers Look to Vaccines for Growth and Innovation

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
Feb 2, 2010

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.

Pharma Faces Multiple Challenges in the Year Ahead

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.
Jan 2, 2010

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here